Tuesday, October 17, 2017
Close  
business /

Transplant medicine recalled

business /
  • share this

Transplant medicine recalled

/ 10:14 AM May 11, 2014

AFP FILE PHOTO

MANILA, Philippines—A pharmaceutical firm has voluntarily recalled from the market a drug used in organ transplants and the treatment of aplastic anemia.

In an advisory, the Food and Drug Administration (FDA) said Sanofi-Aventis Philippines Inc. has initiated a voluntary recall of three batches of Rabbit Anti-Human Thymocyte Immunoglobulin, or Thymoglobuline.

“Due to out of specification (OOS) findings on the product stability prior to the expiration date, specific batches of Rabbit Anti-Human Thymocyte Immunoglobulin (Thymoglobuline) 5mg/mL Powder for Solution for IV Infusion has been voluntarily recalled,” the FDA said.

ADVERTISEMENT

Covered by the recall order are Thymoglobuline batches C1272H08 with expiry date of March 2014, C1282H20 and C1282H31, with expiry dates of May 2014.

The drug was manufactured by Genzyme Polyclonals S.A.S in France. Tina G. Santos

RELATED STORIES

 

Filipinos make up biggest clientele of German fresh-cell therapy center

Mother’s medicine

ADVERTISEMENT

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Aplastic Anemia, Food and Drug Administration, Health Science, medicine, Pharmaceutical Firm, Sanofi-Aventis
For feedback, complaints, or inquiries, contact us.




© Copyright 1997-2016 INQUIRER.net | All Rights Reserved